Carcinoma, Hepatocellular

Showing NaN - NaN of 45

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Hepatocellular Trial in Worldwide (drug, biological, procedure)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Tucson, Arizona
  • +206 more
Jan 31, 2023

Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Seoul (Microwave ablation)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +3 more
  • Microwave ablation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 23, 2023

Lenvima in Korean Unresectable Hepatocellular Carcinoma

Completed
  • Liver Neoplasms
  • Carcinoma, Hepatocellular
  • Non-interventional
  • Cheonan, Chungcheongnam-do, Korea, Republic of
  • +41 more
Jan 6, 2023

Carcinoma, Hepatocellular, Hepatoma Trial in Seongnam, Seoul (Regorafenib/Nivolumab)

Completed
  • Carcinoma, Hepatocellular
  • Hepatoma
  • Seongnam, Korea, Republic of
  • +2 more
Dec 4, 2022

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Tepotinib 300 mg, Tepotinib 500 mg, Tepotinib 1000 mg)

Completed
  • Carcinoma, Hepatocellular
  • Tepotinib 300 mg
  • +4 more
  • Beijing, Beijing, China
  • +42 more
Aug 22, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +138 more
Aug 22, 2022

Carcinoma, Hepatocellular, Colorectal Tumors, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Pembrolizumab, Belzutifan,

Recruiting
  • Carcinoma, Hepatocellular
  • +5 more
  • Duarte, California
  • +39 more
Jul 29, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab, Sorafenib)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Phoenix, Arizona
  • +118 more
Jun 14, 2022

Carcinoma, Hepatocellular, Body Weight Trial in Seoul (low dose CT contrast media - lean body weight, Standard dose CT contrast

Completed
  • Carcinoma, Hepatocellular
  • Body Weight
  • low dose CT contrast media - lean body weight
  • Standard dose CT contrast media
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 27, 2022

Carcinoma, Hepatocellular Trial in Worldwide (biological, drug, other)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • pembrolizumab
  • +2 more
  • Hefei, Anhui, China
  • +40 more
Mar 3, 2022

Carcinoma, Hepatocellular Trial in Seoul (Theraspere)

Completed
  • Carcinoma, Hepatocellular
  • Theraspere
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 31, 2021

Carcinoma, Hepatocellular Trial in Seoul (Immuncell-LC)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Immuncell-LC
  • Seoul, Banpo-daero 222 / Seocho-go, Korea, Republic of
  • +2 more
Apr 14, 2021

Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766), Sorafenib (BAY43-9006))

Completed
  • Carcinoma, Hepatocellular
  • Refametinib (BAY86-9766)
  • Sorafenib (BAY43-9006)
  • Louisville, Kentucky
  • +78 more
Apr 6, 2021

Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766))

Completed
  • Carcinoma, Hepatocellular
  • Refametinib (BAY86-9766)
  • Washington, District of Columbia
  • +57 more
Apr 6, 2021

Carcinoma, Hepatocellular Trial in Seoul (No-touch RFA arm, Conventional tumor puncture RFA arm)

Recruiting
  • Carcinoma, Hepatocellular
  • No-touch RFA arm
  • Conventional tumor puncture RFA arm
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 17, 2021

Radiofrequency Ablation, Carcinoma, Hepatocellular Trial in Seoul (RFA using combined bipolar and monopolar energy deliver)

Recruiting
  • Radiofrequency Ablation
  • Carcinoma, Hepatocellular
  • RFA using combined bipolar and monopolar energy deliver
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 16, 2021

Carcinoma, Hepatocellular Trial in Seoul (Avelumab)

Completed
  • Carcinoma, Hepatocellular
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 15, 2021

Radiofrequency Ablation, Carcinoma, Hepatocellular Trial in Seoul (RFA using gradual RF energy delivery mode with Octopus

Recruiting
  • Radiofrequency Ablation
  • Carcinoma, Hepatocellular
  • RFA using gradual RF energy delivery mode with Octopus electrodes
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 16, 2021

Carcinoma, Hepatocellular Trial in Incheon, Seoul (Genexol-PM)

Terminated
  • Carcinoma, Hepatocellular
  • Incheon, Korea, Republic of
  • +1 more
Feb 2, 2021

Carcinoma, Hepatocellular Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo)

Completed
  • Carcinoma, Hepatocellular
  • Regorafenib (Stivarga, BAY73-4506)
  • Placebo
  • Los Angeles, California
  • +146 more
Aug 11, 2020

Carcinoma, Hepatocellular Trial in Worldwide (Placebo, GC33)

Completed
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +56 more
Apr 1, 2020

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (JNJ-42756493 (erdafitinib))

Completed
  • Carcinoma, Hepatocellular
  • JNJ-42756493 (erdafitinib)
  • Changchun, China
  • +9 more
Feb 17, 2020

Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Erlotinib (Tarceva), Placebo)

Completed
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • +2 more
  • San Francisco, California
  • +126 more
May 16, 2019

Carcinoma, Hepatocellular, Chronic Hepatitis B Trial in Seoul (PEIT, RFTA)

Completed
  • Carcinoma, Hepatocellular
  • Chronic Hepatitis B
  • PEIT
  • RFTA
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 14, 2019